Cara Therapeutics to Announce Second Quarter 2022 Financial Results on August 8, 2022
August 01 2022 - 4:01PM
Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage
biopharmaceutical company leading a new treatment paradigm to
improve the lives of patients suffering from pruritus, today
announced the Company will host a conference call and live audio
webcast on Monday, August 8, 2022, at 4:30 p.m. ET to report second
quarter 2022 financial results and provide a corporate update.
To participate in the conference call, please
register here. Registrants will receive the dial-in numbers and a
unique PIN.
A live audio webcast and archived replay of the
call will be available under “Events & Presentations” in the
News & Investors section of the Company’s website at
www.CaraTherapeutics.com.
About Cara Therapeutics
Cara Therapeutics is a commercial-stage biopharmaceutical
company leading a new treatment paradigm to improve the lives of
patients suffering from pruritus. The Company’s novel KORSUVA™
(difelikefalin) injection is the first and only FDA-approved
treatment for moderate-to-severe pruritus associated with chronic
kidney disease in adults undergoing hemodialysis. The Company is
developing an oral formulation of difelikefalin and has initiated
Phase 3 programs for the treatment of pruritus in patients with
non-dialysis dependent advanced chronic kidney disease and atopic
dermatitis. The Company has completed the placebo-controlled phase
of a Phase 2 proof-of-concept trial of oral difelikefalin for the
treatment of moderate-to-severe pruritus in patients with notalgia
paresthetica. A Phase 2 proof-of-concept trial in primary biliary
cholangitis patients with moderate-to-severe pruritus is ongoing.
For more information, visit www.CaraTherapeutics.com and follow the
company on Twitter, LinkedIn and Instagram.
MEDIA CONTACT:Annie Spinetta6
Degrees973-768-2170aspinetta@6degreespr.com
INVESTOR CONTACT:Iris Francesconi, Ph.D.Cara
Therapeutics203-406-3700investor@caratherapeutics.com
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Apr 2024 to May 2024
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From May 2023 to May 2024